In addition to meeting the primary endpoint of non-inferiority for overall response rate (ORR) in the BRUIN CLL-314 study, pirtobrutinib achieved a numerically higher ORR of 87.0% compared to 78.5% ...
The Musical. Here, the show’s humming along rather enjoyably, and then when they start to sing, it feels like you’ve just driven into one of those expensive carparks Sydney entertainingly calls a ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback